TRIM59, amplified in ovarian cancer, promotes tumorigenesis through the MKP3/ERK pathway.

MLA

Tong, Xiaojing, et al. “TRIM59, Amplified in Ovarian Cancer, Promotes Tumorigenesis through the MKP3/ERK Pathway.” Journal of Cellular Physiology, vol. 235, no. 11, Nov. 2020, pp. 8236–45. EBSCOhost, https://doi.org/10.1002/jcp.29478.

APA

Tong, X., Mu, P., Zhang, Y., Zhao, J., & Wang, X. (2020). TRIM59, amplified in ovarian cancer, promotes tumorigenesis through the MKP3/ERK pathway. Journal of Cellular Physiology, 235(11), 8236–8245. https://doi.org/10.1002/jcp.29478

Chicago

Tong, Xiaojing, Peng Mu, Yuhua Zhang, Jiao Zhao, and Xiaobin Wang. 2020. “TRIM59, Amplified in Ovarian Cancer, Promotes Tumorigenesis through the MKP3/ERK Pathway.” Journal of Cellular Physiology 235 (11): 8236–45. doi:10.1002/jcp.29478.